3186 results for «3557»
3186 results
Late-breaking trials: TAVI head-to-head
14 May 2024 – From EuroPCR 2024
This session presents the latest findings from several late-breaking trials comparing different transcatheter aortic valve implantation (TAVI) approaches. Topics include outcomes in women with small aortic annuli, the comparison of percutaneous versus surgical treatment for patients with aortic stenosis and coronary disease, the impact of valve...
Different treatment options for PCI in calcified lesions
15 May 2024 – From EuroPCR 2024
This session showcases various treatment options for percutaneous coronary intervention (PCI) in calcified lesions. Attendees will learn about the use of excimer laser atherectomy, intravascular lithotripsy, and other techniques to effectively manage challenging calcified coronary lesions. The session features case presentations and discussions, providing insights into...
Treatment strategies in complex coronary
14 May 2024 – From EuroPCR 2024
This session comprises a selection of complex coronary intervention cases from the EuroPCR 2024 Clinical Case submissions. The cases cover a range of challenging scenarios, including CTO with left ventricular dysfunction and VT storm, subintimal tracking and re-entry, and the decision between native vessel CTO PCI...
NSTEMI in patients in post CABG: a challenging combination
15 May 2024 – From EuroPCR 2024
This session focuses on the management of non-ST-elevation myocardial infarction (NSTEMI) in patients who have previously undergone coronary artery bypass grafting (CABG). Attendees will explore various case presentations and discussions on the challenges and treatment strategies for this complex clinical scenario, including the use of intravascular...
Endovascular treatment for acute chronic heart failure
14 May 2024 – From EuroPCR 2024
This session comprises a selection of complex endovascular cases for the treatment of acute chronic heart failure, including the use of 3D printing and virtual reality to close a pulmonary arteriovenous malformation, closure of a post-septal myectomy ventricular septal defect, and catheter-based treatment of a heart...
Stentless PCI
15 May 2024 – From EuroPCR 2024
This session explores various stentless percutaneous coronary intervention (PCI) strategies, including drug-coated balloon (DCB)-only PCI for chronic total occlusions and de-novo coronary lesions, as well as the use of magnesium resorbable scaffolds. Attendees will learn about the rationale, techniques, and outcomes of these "leave nothing behind"...
Innovating techniques for the treatment of coronary artery disease
14 May 2024 – From EuroPCR 2024
This session showcases innovative techniques for the treatment of coronary artery disease, including minimum contrast PCI with guide extension catheter and IVUS co-registration, management of iatrogenic aortic dissection using 3D-hologram and computational fluid dynamics, a novel tunnelling technique for huge coronary bypass graft aneurysms, and a...
Treating the right valves: not always a straightforward task
15 May 2024 – From EuroPCR 2024
This session focuses on the challenges and complexities involved in the percutaneous treatment of right-sided heart valves, including the tricuspid and pulmonary valves. Attendees will learn from case presentations and discussions on various scenarios, such as recurrent right heart obstructive shock, paravalvular leak closure, and unusual...
PCI complications: device-related issues, perforations and other unexpected events
15 May 2024 – From EuroPCR 2024
This session focuses on the management of various complications that can occur during percutaneous coronary intervention (PCI), including device-related issues, perforations, and other unexpected events. Attendees will learn from case presentations and discussions on strategies to identify, mitigate, and manage these complications, with a focus on...
TAVI in bicuspid stenosis: complex situations
14 May 2024 – From EuroPCR 2024
This session comprises selected clinical case submissions focused on TAVI (Transcatheter Aortic Valve Implantation) in patients with bicuspid aortic stenosis. Participants will learn about complex scenarios, including fusion raphe, hostile bicuspid anatomy, large annulus, and early TAVR dysfunction. The session features case presentations followed by audience...
Innovations and novel strategies in CTO PCI
15 May 2024 – From EuroPCR 2024
This session showcases innovative and novel strategies for the percutaneous treatment of chronic total occlusions (CTO) in the coronary arteries. Attendees will learn about techniques such as subintimal rotational ablation with retrograde guidance, external calcium modification, and the use of intravascular lithotripsy to optimize stenting in...
Management complications during PCI of calcified coronary lesions
14 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions showcasing the management of complications that can arise during PCI (Percutaneous Coronary Intervention) of calcified coronary lesions. Participants will learn about various challenging scenarios, such as impacted diamond crown, stuck IVUS catheter post-stenting, and ruptured/fractured cutting balloon. The session...
Challenging scenarios in STEMI
14 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions highlighting challenging scenarios in the management of STEMI (ST-Elevation Myocardial Infarction) patients. Participants will learn about complex cases, such as left main time bomb, coronary anomalies, simultaneous two-vessel acute coronary thrombosis, and mechanical complications. The session includes case presentations...
Undilatable calcified lesion with balloon - LIVE case
15 May 2024 – From EuroPCR 2024
A 66-year-old male with a history of PAD, COPD, diabetes, and an LV function of 44% presented with unstable angina. Coronary angiography revealed a severe and heavily calcified RCA lesion undilatable with a balloon. The patient was referred to a centre specializing in calcified lesion treatment.
Using...
Left main and complex bifurcation stenting
14 May 2024 – From EuroPCR 2024
Watch this session focused on a patient with distal left main stenosis to understand that the stepwise provisional side branch (SB) stenting strategy is the standard approach for most left main trifurcation lesions. Discover the importance of optical frequency domain imaging for strategy determination and bifurcation...
Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options
15 May 2024 – From EuroPCR 2024
In this session, uncover new data on Murray-law based quantitative flow ratio (muFR) assessment, providing a comprehensive understanding of PCI outcomes from a single angiographic view, explore the innovative application of artificial intelligence in identifying vulnerable plaque and assessing hemodynamic stenosis significance through the analysis of...
From innovation to reality: the impact of Cre8 EVO technology on complex PCI
15 May 2024 – From EuroPCR 2024
This session is a good opportunity to delve into the contemporary technical and clinical complexities surrounding complex PCIs in challenging patient cases. Explore the necessary tools and treatment strategies to enhance peri-procedural and long-term clinical outcomes, and follow discussions on the unique technologies of Cre8 EVO...
Align for the future with next-generation balloon expandable transcatheter heart valve technology
14 May 2024 – From EuroPCR 2024
Tune in to this EuroPCR 2024 session to explore the Myval Octacor THV, a cutting-edge balloon-expandable transcatheter heart valve. Discover its advanced features, potential clinical benefits, and procedural impact. Learn about the latest updates on the Myval THV series and the LANDMARK RCT. Explore the OctaAlign technique for...
Complex PCI in ACS patient with high bleeding risk: optimise the strategy
15 May 2024 – From EuroPCR 2024
Watch this session for insights into managing acute coronary syndrome patients with multivessel disease, updates on treatment approaches, comparing FULL RESVAC with previous trials like COMPLETE or FIRE, for example, and information on ongoing trials such as FRAMI-AMI 2 and 3. Explore the LIVE case presentation...
LANDMARK RCT - Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
15 May 2024 – From EuroPCR 2024
This session provides an overview of the early outcomes of the LANDMARK trial, a randomized non-inferiority trial comparing TAVI devices. It examines baseline characteristics, the significance of intermediate sizes according to MSCT recommendations, real-world representative cases from the LANDMARK RCT, insights from quantitative aortography and echocardiography...
